The definition of triple-negative breast cancer is based on clinical observations; the tumor must lack estrogen receptors (ERs), progesterone receptors (PRs), and hormone epidermal growth factor receptor type 2 (HER-2) expression. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.